4 results

An antibody cocktail from Regeneron significantly reduced the risk of death among hospitalised Covid-19 patients whose own immune systems have failed to fight the virus, a large British clinical trial has shown.  Photograph:  Joe Giddens/PA Wire

(...). A combination of two antibodies called Regen-Cov, made by the US-based biotech company, cuts(...)

Scientist Xinhua Yan works in the Moderrna lab. The company  reported antibodies in all patients and no safety issues in an early clinical trial. Photograph:  David L. Ryan/The Boston Globe via Getty Images

(...)’s vaccine candidate produced antibodies in all 45 participants in the first cohort of the phase one trial(...)

Finbarr Kenny: ‘What we can determine is whether someone has recently been infected with the virus and that has caused an immune response’

(...) major player in molecular testing for Covid-19 analysis.” Presence of antibodies This is the platform(...)

Initial results show that an experimental Covid-19 vaccine from Moderna shows promise in a small early-stage trial.

(...) that it produced protective antibodies in a small group of healthy volunteers, the company said on(...)